Ubs Group Ag Sera Prognostics, Inc. Call Options Transaction History
Ubs Group Ag
- $555 Billion
- Q2 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding SERA
# of Institutions
64Shares Held
23.2MCall Options Held
12.3KPut Options Held
100-
Baker Bros. Advisors LP New York, NY5.5MShares$17.6 Million0.15% of portfolio
-
Whetstone Capital Advisors, LLC Shawnee Mission, KS3.63MShares$11.7 Million3.67% of portfolio
-
Interwest Venture Management CO2.42MShares$7.76 Million21.78% of portfolio
-
Abrdn PLC2.23MShares$7.15 Million0.01% of portfolio
-
Vivo Capital, LLC Palo Alto, CA1.65MShares$5.3 Million0.97% of portfolio
About SERA PROGNOSTICS, INC.
- Ticker SERA
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 29,596,900
- Market Cap $95M
- Description
- Sera Prognostics, Inc., a women's health diagnostic company, discovers, develops, and commercializes biomarker tests for improving pregnancy outcomes. The company develops PreTRM test, a blood-based biomarker test to predict the risk of spontaneous preterm birth in asymptomatic singleton pregnancies. It is also developing a portfolio of product ...